# The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

> **NCT05460546** · PHASE2 · COMPLETED · sponsor: **Beijing Konruns Pharmaceutical Co., Ltd.** · enrollment: 180 (actual)

## Conditions studied

- Chronic Pelvic Pain

## Interventions

- **DRUG:** Jincaopian Tablets high dose
- **DRUG:** Jincaopian Tablets low dose
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05460546
- **Lead sponsor:** Beijing Konruns Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-19
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2022-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05460546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05460546, "The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05460546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*